5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Hepatitis B e Antigen Induces NKG2A + Natural Killer Cell Dysfunction via Regulatory T Cell-Derived Interleukin 10 in Chronic Hepatitis B Virus Infection

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Although persistent hepatitis B virus (HBV) infection is associated with natural killer (NK) cell dysfunction, it remains obscure whether HBV viral antigens are responsible for NK cell dysfunction in patients with chronic hepatitis B (CHB) infection. In this study, we found that the percentage of NK cells expressing the inhibitory receptor, NKG2A, was increased in CHB patients, and NKG2A blockade restored NK cell function. Furthermore, in CHB patients, the frequency of NK cells expressing NKG2A positively correlated with the number of regulatory T cells (Tregs) and production of interleukin-10 (IL-10) in these Tregs. Moreover, exposure of peripheral blood mononuclear cells (PBMCs) isolated from healthy controls to sera from CHB patients resulted in increased proportion of NKG2A + NK cells; IL-10 blockade reduced the frequency of NKG2A + NK cells while increasing the percentage of IFN-γ + NK cells. In addition, stimulation of NK cells and Tregs from healthy controls with CHB sera together with anti-IL-10 antibody increased IFN-γ production in the culture supernatant. The frequencies of NKG2A + NK cells and IL-10 + Tregs, along with serum levels of alanine transferase and HBV DNA, were significantly increased in CHB patients positive for the Hepatitis B e antigen (HBeAg, a marker of viral replication) when compared to HBeAg-negative CHB patients. Importantly, exposure of PBMCs from healthy controls to HBeAg resulted in increased IL-10 production but reduced levels of TNF and IFN-γ, and IL-10 blockade rescued the generation of TNF and IFN-γ in this assay. The reduced production of TNF and IFN-γ was also observed in NK cells and Tregs from healthy controls that were stimulated with HBeAg, while IL-10 blockade increased the secretion of these two cytokines. We conclude that HBeAg induces IL-10 production in Tregs, thereby leading to increased expression of NKG2A on NK cells, which contributes to NK cell dysfunction during CHB infection. These data suggest that HBeAg is associated with NK cell dysfunction in CHB.

          Related collections

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: not found

          Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.

          T cells play a critical role in viral infection. We examined whether T-cell effector and regulatory responses can define clinical stages of chronic hepatitis B (CHB).
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            TGF-β-dependent induction of CD4⁺CD25⁺Foxp3⁺ Tregs by liver sinusoidal endothelial cells.

            CD4(+) CD25(+) Foxp3(+) regulatory T cells (Tregs) have a profound ability to control immune responses. We have previously shown that the liver is a major source of peripherally induced Tregs. Here, we investigate the liver cell types and molecular mechanisms responsible for hepatic Treg induction.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Liver-Mediated Adaptive Immune Tolerance

              The liver is an immunologically tolerant organ that is uniquely equipped to limit hypersensitivity to food-derived antigens and bacterial products through the portal vein and can feasibly accept liver allografts. The adaptive immune response is a major branch of the immune system that induces organ/tissue-localized and systematic responses against pathogens and tumors while promoting self-tolerance. Persistent infection of the liver with a virus or other pathogen typically results in tolerance, which is a key feature of the liver. The liver's immunosuppressive microenvironment means that hepatic adaptive immune cells become readily tolerogenic, promoting the death of effector cells and the “education” of regulatory cells. The above mechanisms may result in the clonal deletion, exhaustion, or inhibition of peripheral T cells, which are key players in the adaptive immune response. These tolerance mechanisms are believed to be responsible for almost all liver diseases. However, optimal protective adaptive immune responses may be achieved through checkpoint immunotherapy and the modulation of hepatic innate immune cells in the host. In this review, we focus on the mechanisms involved in hepatic adaptive immune tolerance, the liver diseases caused thereby, and the therapeutic strategies needed to overcome this tolerance.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Cell Dev Biol
                Front Cell Dev Biol
                Front. Cell Dev. Biol.
                Frontiers in Cell and Developmental Biology
                Frontiers Media S.A.
                2296-634X
                03 June 2020
                2020
                : 8
                : 421
                Affiliations
                [1] 1Department of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University , Hefei, China
                [2] 2Department of Clinical Laboratory, Chaohu Hospital of Anhui Medical University , Chaohu, China
                [3] 3Department of Blood Transfusion, The First Affiliated Hospital of Anhui Medical University , Hefei, China
                [4] 4Department of Life Sciences and Medicine, The First Affiliated Hospital, University of Science and Technology of China , Hefei, China
                [5] 5Department of Infectious Diseases, The First Affiliated Hospital, Anhui Medical University , Hefei, China
                Author notes

                Edited by: Giulia De Falco, Queen Mary University of London, United Kingdom

                Reviewed by: Taro Yamashita, Kanazawa University, Japan; Ye Zhang, Tangdu Hospital, China

                *Correspondence: Yufeng Gao, aygyf@ 123456126.com

                These authors have contributed equally to this work

                This article was submitted to Molecular Medicine, a section of the journal Frontiers in Cell and Developmental Biology

                Article
                10.3389/fcell.2020.00421
                7283553
                32582704
                e995ed47-8728-4964-88d4-e87b132eed3b
                Copyright © 2020 Ma, Dong, Liu, Zhong, Sun, Zong, Zhao, Lu, Zhang, Gao, Ye, Cheng, Xu and Zheng.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 07 January 2020
                : 06 May 2020
                Page count
                Figures: 7, Tables: 1, Equations: 0, References: 46, Pages: 12, Words: 0
                Funding
                Funded by: Innovative Research Group Project of the National Natural Science Foundation of China 10.13039/100014718
                Categories
                Cell and Developmental Biology
                Original Research

                hepatitis b e antigen,hbv,nk cell,nkg2a,il-10
                hepatitis b e antigen, hbv, nk cell, nkg2a, il-10

                Comments

                Comment on this article